Objective

To evaluate the efficacy of the Protect 900 on reducing methicillin-resistant Staphylococcus aureus (MRSA).

Methodology

The challenge bacteria were aerosolized using a six-jet collision nebulizer under high pressure air and introduced into the chamber with the Protect 900.

Summary of Results

The Protect 900 reduced 99.99% of methicillin-resistant Staphylococcus aureus (MRSA) bacteria over the course of four hours.